Johns Hopkins School of Nursing, Baltimore, MD.
The Johns Hopkins Hospital, Baltimore, MD.
Am J Speech Lang Pathol. 2019 Aug 9;28(3):1019-1028. doi: 10.1044/2019_AJSLP-18-0187. Epub 2019 Jul 17.
Purpose The purpose of this clinical focus article is to describe the frequency, indications, and outcomes of fenestrated tracheostomy tube use in a large academic institution. Method A retrospective chart review was conducted to evaluate the use of fenestrated tracheostomy tubes between 2007 and 2017. Patients were included in the study if they were ≥ 18 years of age and received a fenestrated tracheostomy tube in the recent 10-year period. Results Of 2,000 patients who received a tracheostomy, 15 patients had a fenestrated tracheostomy tube; however, only 5 patients received a fenestrated tracheostomy tube at the study institution. The primary reason why the 15 patients received a tracheostomy was chronic respiratory failure (73%); other reasons included airway obstruction (20%) and airway protection (7%). Thirteen (87%) patients received a fenestrated tracheostomy tube for phonation purposes. The remaining 2 patients received it as a step to weaning. Of the 13 patients who received a fenestrated tracheostomy tube for phonation, only 1 patient was not able to phonate. Nine (60%) patients developed some type of complications: granulation only, 2 (13.3%); granulation and tracheomalacia, 2 (13.3%); granulation and stenosis, 4 (26.7%); and granulation, tracheomalacia, and stenosis, 1 (6.7%). Conclusions Fenestrated tracheostomy tubes may assist with phonation in patients who cannot tolerate a 1-way speaking valve; however, the risk of developing granulation tissue, tracheomalacia, and tracheal stenosis exists. Health care providers should be educated on the safe use of a fenestrated tracheostomy tube and other options available to improve phonation while ensuring patient safety.
目的 本临床重点文章旨在描述在大型学术机构中使用开窗式气管造口管的频率、适应证和结果。
方法 对 2007 年至 2017 年期间使用开窗式气管造口管的情况进行回顾性图表审查。如果患者年龄≥18 岁且在最近 10 年内接受了开窗式气管造口管,则将其纳入研究。
结果 在接受气管造口术的 2000 例患者中,有 15 例患者使用了开窗式气管造口管;然而,只有 5 例患者在研究机构接受了开窗式气管造口管。这 15 例患者接受气管造口术的主要原因是慢性呼吸衰竭(73%);其他原因包括气道阻塞(20%)和气道保护(7%)。13 例(87%)患者因发音目的接受了开窗式气管造口管。其余 2 例患者接受了该手术以进行脱机。在因发音目的而接受开窗式气管造口管的 13 例患者中,仅有 1 例患者无法发音。9 例(60%)患者出现了某种类型的并发症:单纯肉芽组织形成 2 例(13.3%);肉芽组织形成伴气管软化 2 例(13.3%);肉芽组织形成伴狭窄 4 例(26.7%);以及肉芽组织形成、气管软化和狭窄各 1 例(6.7%)。
结论 开窗式气管造口管可帮助无法耐受单通说话阀的患者发音;然而,存在形成肉芽组织、气管软化和气管狭窄的风险。应向医疗保健提供者提供有关安全使用开窗式气管造口管的教育以及其他可改善发音同时确保患者安全的选择。